.png)
.png)
Objective: The aim of this study is to evaluate the efficacy of glycemic control of Care Connect, a program based on digital tools designed for remote monitoring of type 1 diabetes patients.
Methods: This is a retrospective cohort study that assesses glycemic control, at baseline and after 3 months, in patients included in the first 45 days whose data were downloaded at least twice during the observation period.
Results: Fifty-three subjects were included in the portal in the first 45 days after implantation, 27 men and 26 women, mean age 44.5 ± 11.69 years, all of them were closed-loop system users. Three months after starting remote monitoring, the glucose management indicator decreased from 7.04% ± 0.53% to 6.89% ± 0.45%, the percentage of time in hyperglycemia> 250 mg/dL reduced from 7.83% ± 8.13% to 5.04% ± 5.9% and the percentage of time in hyperglycemia> 180 mg/dL reduced from 23.06% ± 12.92% to 19.17% ± 9.71% while the percentage of time in range increased from 65.52% ± 17.80% to 73.60% ± 13.98%, all these differences being statistically significant.
Conclusions: A care program based on digital tools can improve glycemic control in type 1 diabetic patients using a closed-loop system. This type of digital health technology could be useful to optimize control in this patient profile.
Cite this article as: Garcia MJA, Izquierdo FJE, Vaquero AAC, et al. Assessment of a program based on digital tools in monitoring type 1 diabetes patients using closed-loop systems. Endocrinol Res Pract. 2023;27(2):48-53.